| 注册
首页|期刊导航|四川医学|依那西普联合甲氨蝶呤与甲氨蝶呤单用比较治疗类风湿关节炎有效性和安全性的Meta分析

依那西普联合甲氨蝶呤与甲氨蝶呤单用比较治疗类风湿关节炎有效性和安全性的Meta分析

吴逢波 孙闻续 黄媛 刘静 徐珽

四川医学2016,Vol.37Issue(10):1144-1148,5.
四川医学2016,Vol.37Issue(10):1144-1148,5.DOI:10.16252/j.cnki.issn1004-0501-2016.10.023

依那西普联合甲氨蝶呤与甲氨蝶呤单用比较治疗类风湿关节炎有效性和安全性的Meta分析

Efficacy and Safety of Treatment in Rheumatoid Arthritis with Etanercept and Methotrexate Compared with Metho-trexate Alone:A Meta-analysis

吴逢波 1孙闻续 1黄媛 1刘静 1徐珽1

作者信息

  • 1. 四川大学华西医院临床药学部,四川 成都610041
  • 折叠

摘要

Abstract

Objective Systematic evaluation on efficacy and safety of treatment in rheumatoid arthritis withetanercept and methotrexate compared with methotrexate alone. Methods Searches of Web of Science,Medline Embase,Cochrane Library,CBM, VIP,CJFDandWan Fang Database were all updated to Dec. 2015. Randomized controlled trials included were evaluated in methodo-logical quality according to the Cochrane systematic evaluation method with RevMan 5. 3 software for Meta analysis. Results Nine randomized controlled trials,1005 patients were included. Meta analysis results showed that,the curative effect of etanercept com-bined with methotrexate was superior to methotrexate alone group in the total effective rate,American College of Rheumatology RA remission ACR20,ACR50,ACR70,c-reactive protein(CRP),erythrocyte sedimentation rate(ESR),rheumatoid factor(RF),tender joint count(DAS28),rest pain(VAS),adverse drug reactions(ADR),etc. The difference was statistically significant(P<0. 05);In terms of ACR-N AUC and the incidence of ADR,the differences between the two groups had no statistical significance( P>0. 05). Conclusion The curative effect of etanercept combined with methotrexate is superior to methotrexate alone,but the quality of tests included is low,the conclusion also need high quality,large sample research for further validation.

关键词

依那西普/甲氨蝶呤/类风湿关节炎/Meta分析

Key words

etanercept/methotrexate/rheumatoidarthritis/meta-analysis

分类

医药卫生

引用本文复制引用

吴逢波,孙闻续,黄媛,刘静,徐珽..依那西普联合甲氨蝶呤与甲氨蝶呤单用比较治疗类风湿关节炎有效性和安全性的Meta分析[J].四川医学,2016,37(10):1144-1148,5.

四川医学

OACSTPCD

1004-0501

访问量0
|
下载量0
段落导航相关论文